Drug Profile
GTOP 99
Alternative Names: B Cell lymphoma vaccine - Genitope; MyVaxLatest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Genitope Corporation
- Developer Genitope Corporation; University of Nebraska Medical Center
- Class Cancer vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Chronic lymphocytic leukaemia; Lymphoma; Non-Hodgkin's lymphoma
Most Recent Events
- 16 Apr 2008 Final efficacy data from a phase III trial in Follicular Non-Hodgkin's lymphoma presented at the 99th Annual Meeting of the American Association for Cancer Research (AACR-2008)
- 11 Mar 2008 Suspended - Phase-I/II for Chronic lymphocytic leukaemia in USA (SC)
- 11 Mar 2008 Suspended - Phase-III for Lymphoma in Canada (SC)